Bio-Techne
TECH
#1613
Rank
$9.74 B
Marketcap
$61.97
Share price
-1.21%
Change (1 day)
-27.29%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2023 (TTM): $1.57

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is $1.57. In 2022 the company made an earnings per share (EPS) of $1.67 an increase over its 2021 EPS that were of $1.34.

EPS history for Bio-Techne from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.57-6.13%
2022$1.6724.35%
2021$1.3417.98%
2020$1.14-10.94%
2019$1.28101.57%
2018$0.64-17.53%
2017$0.7739.37%
2016$0.55-17.23%
2015$0.67-14.97%
2014$0.781.29%
2013$0.783.68%
2012$0.75-1.97%
2011$0.761.67%
2010$0.757.14%
2009$0.70-1.06%
2008$0.7119.41%
2007$0.5919.1%
2006$0.5010.56%
2005$0.4529.5%
2004$0.3513.05%
2003$0.3168.43%
2002$0.18-17.05%
2001$0.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$15.34 877.07%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.55 253.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.55 444.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.02 410.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.45-7.38%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
-$0.94-159.87%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.72-464.33%๐Ÿ‡บ๐Ÿ‡ธ USA